NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|490280039|ref|WP_004175970|]
View 

MULTISPECIES: N-hydroxyarylamine O-acetyltransferase [Klebsiella]

Protein Classification

arylamine N-acetyltransferase family protein( domain architecture ID 1395)

arylamine N-acetyltransferase family protein similar to arylamine N-acetyltransferase that catalyzes the transfer of an acetyl group from acetyl coenzyme A (CoA) to the nitrogen or oxygen atom of a wide variety of aromatic amines (arylamines) and hydrazines

CATH:  3.30.2140.20
EC:  2.3.1.-
Gene Ontology:  GO:0016407
SCOP:  4000879

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
Acetyltransf_2 super family cl00949
N-acetyltransferase; Arylamine N-acetyltransferase (NAT) is a cytosolic enzyme of ...
1-281 0e+00

N-acetyltransferase; Arylamine N-acetyltransferase (NAT) is a cytosolic enzyme of approximately 30kDa. It facilitates the transfer of an acetyl group from Acetyl Coenzyme A on to a wide range of arylamine, N-hydroxyarylamines and hydrazines. Acetylation of these compounds generally results in inactivation. NAT is found in many species from Mycobacteria (M. tuberculosis, M. smegmatis etc) to man. It was the first enzyme to be observed to have polymorphic activity amongst human individuals. NAT is responsible for the inactivation of Isoniazid (a drug used to treat Tuberculosis) in humans. The NAT protein has also been shown to be involved in the breakdown of folic acid.


The actual alignment was detected with superfamily member PRK15047:

Pssm-ID: 470008  Cd Length: 281  Bit Score: 539.82  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 490280039   1 MSPFLRAYFSRLSWTGEPDVSIDTLRELHLQHNSAIPFENLDVLLPREIHLDDGALEEKLIAARRGGYCFEQNGLLERAL 80
Cdd:PRK15047   1 MTPFLNAYFARINWSGAAAVNIDTLRALHLKHNCTIPFENLDVLLPREIQLDDQSLEEKLVIARRGGYCFEQNGLFERVL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 490280039  81 REIGFNVRSLLGRVVLANPPQMPPRTHRLLLVEVAGERWIADVGFGGQTLTAPIKLLADIPQQTPHGSYRLVHEGDEWTL 160
Cdd:PRK15047  81 RELGFNVRSLLGRVVLSNPPALPPRTHRLLLVELEGEKWIADVGFGGQTLTAPIRLVADIVQTTPHGEYRLLQEGDDWVL 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 490280039 161 QFNHHEHWQSMYHFDLGRQYASDYVMGNFWSAHWPQSHFRHHLLMCRHLPDGGKMTLTNFHFTHWENNHVVEKIDFADVS 240
Cdd:PRK15047 161 QFNHHQHWQSMYRFDLCEQQQSDYVMGNFWSAHWPQSHFRHHLLMCRHLPDGGKLTLTNFHFTHYENGHAVEQRNLPDVA 240
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|.
gi 490280039 241 ALYEGLQTRFGLGVDDPKHGFSEAALAAVMAAFDTHPEAGK 281
Cdd:PRK15047 241 SLYAVMQEQFGLGVDDAKHGFTVAELAAVMAAFDTHPEAGK 281
 
Name Accession Description Interval E-value
PRK15047 PRK15047
N-hydroxyarylamine O-acetyltransferase; Provisional
1-281 0e+00

N-hydroxyarylamine O-acetyltransferase; Provisional


Pssm-ID: 185007  Cd Length: 281  Bit Score: 539.82  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 490280039   1 MSPFLRAYFSRLSWTGEPDVSIDTLRELHLQHNSAIPFENLDVLLPREIHLDDGALEEKLIAARRGGYCFEQNGLLERAL 80
Cdd:PRK15047   1 MTPFLNAYFARINWSGAAAVNIDTLRALHLKHNCTIPFENLDVLLPREIQLDDQSLEEKLVIARRGGYCFEQNGLFERVL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 490280039  81 REIGFNVRSLLGRVVLANPPQMPPRTHRLLLVEVAGERWIADVGFGGQTLTAPIKLLADIPQQTPHGSYRLVHEGDEWTL 160
Cdd:PRK15047  81 RELGFNVRSLLGRVVLSNPPALPPRTHRLLLVELEGEKWIADVGFGGQTLTAPIRLVADIVQTTPHGEYRLLQEGDDWVL 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 490280039 161 QFNHHEHWQSMYHFDLGRQYASDYVMGNFWSAHWPQSHFRHHLLMCRHLPDGGKMTLTNFHFTHWENNHVVEKIDFADVS 240
Cdd:PRK15047 161 QFNHHQHWQSMYRFDLCEQQQSDYVMGNFWSAHWPQSHFRHHLLMCRHLPDGGKLTLTNFHFTHYENGHAVEQRNLPDVA 240
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|.
gi 490280039 241 ALYEGLQTRFGLGVDDPKHGFSEAALAAVMAAFDTHPEAGK 281
Cdd:PRK15047 241 SLYAVMQEQFGLGVDDAKHGFTVAELAAVMAAFDTHPEAGK 281
NhoA COG2162
Arylamine N-acetyltransferase [Secondary metabolites biosynthesis, transport and catabolism];
3-256 4.72e-112

Arylamine N-acetyltransferase [Secondary metabolites biosynthesis, transport and catabolism];


Pssm-ID: 441765  Cd Length: 256  Bit Score: 323.37  E-value: 4.72e-112
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 490280039   3 PFLRAYFSRLSWTGEPDVSIDTLRELHLQHNSAIPFENLDVLLPREIHLDDGALEEKLIAARRGGYCFEQNGLLERALRE 82
Cdd:COG2162    3 FDLDAYLARIGYSGPPAPTLETLRALHRAHVRAIPFENLDVLLGRPISLDPDALFDKLVRRRRGGYCYELNGLFAALLEA 82
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 490280039  83 IGFNVRSLLGRVVLANP-PQMPPRTHRLLLVEVAGERWIADVGFGGQTLTAPIKLLADIPQQTPHGSYRLVHE-GDEWTL 160
Cdd:COG2162   83 LGFDVTLLAARVRWGGPgGPGPPRTHMALLVTLDGERWLVDVGFGGGTPLEPLPLEDGTEQDQPGGTYRLVRSdDGEWVL 162
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 490280039 161 QFNHHEHWQSMYHFDLGRQYASDYVMGNFWSAHWPQSHFRHHLLMCRHLPDgGKMTLTNFHFTHWENNHVVEKiDFADVS 240
Cdd:COG2162  163 QRRVDGGWRPLYRFDLEPQELADFEVANWYTSTHPDSPFVGNLLVARATPD-GRVTLRGRRLTRRRGGGEEER-TLLSAE 240
                        250
                 ....*....|....*.
gi 490280039 241 ALYEGLQTRFGLGVDD 256
Cdd:COG2162  241 ELAAVLRERFGLDLDD 256
Acetyltransf_2 pfam00797
N-acetyltransferase; Arylamine N-acetyltransferase (NAT) is a cytosolic enzyme of ...
21-257 5.69e-103

N-acetyltransferase; Arylamine N-acetyltransferase (NAT) is a cytosolic enzyme of approximately 30kDa. It facilitates the transfer of an acetyl group from Acetyl Coenzyme A on to a wide range of arylamine, N-hydroxyarylamines and hydrazines. Acetylation of these compounds generally results in inactivation. NAT is found in many species from Mycobacteria (M. tuberculosis, M. smegmatis etc) to man. It was the first enzyme to be observed to have polymorphic activity amongst human individuals. NAT is responsible for the inactivation of Isoniazid (a drug used to treat Tuberculosis) in humans. The NAT protein has also been shown to be involved in the breakdown of folic acid.


Pssm-ID: 395644  Cd Length: 240  Bit Score: 299.96  E-value: 5.69e-103
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 490280039   21 SIDTLRELHLQHNSAIPFENLDVLLPREIHLDDGALEEKLIAARRGGYCFEQNGLLERALREIGFNVRSLLGRVVLANPP 100
Cdd:pfam00797   1 DLETLRELHLHHLRAIPFENLDVHLGEPISLDLEALFDKLVHKRRGGYCYELNGLFYWVLTELGFDVTLLGGRVYWPRPG 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 490280039  101 -QMPPRTHRLLLVEVAGERWIADVGFGGQTLTAPIKLLADIPQQTPHGSYRLVHEGD-EWTLQFNHHEHWQSMYHFDLGR 178
Cdd:pfam00797  81 aYSTPQTHLLLLVTIDGETYLVDVGFGGSTLWAPLELISGKDQPTPHGIFRLVEEGGgTWYLEKDGRDGWVPLYSFTLEP 160
                         170       180       190       200       210       220       230
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 490280039  179 QYASDYVMGNFWSAHWPQSHFRHHLLMCRHLPDgGKMTLTNFHFTHWENNHVVEKIDFADVSALYEGLQTRFGLGVDDP 257
Cdd:pfam00797 161 RQIEDFEVGNDYLQTSPDSHFTTHLLCSRQTPD-GRLTLTGRTLTLRYKDGALVEIRLLTDEEVEDVLKERFGIELDAK 238
 
Name Accession Description Interval E-value
PRK15047 PRK15047
N-hydroxyarylamine O-acetyltransferase; Provisional
1-281 0e+00

N-hydroxyarylamine O-acetyltransferase; Provisional


Pssm-ID: 185007  Cd Length: 281  Bit Score: 539.82  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 490280039   1 MSPFLRAYFSRLSWTGEPDVSIDTLRELHLQHNSAIPFENLDVLLPREIHLDDGALEEKLIAARRGGYCFEQNGLLERAL 80
Cdd:PRK15047   1 MTPFLNAYFARINWSGAAAVNIDTLRALHLKHNCTIPFENLDVLLPREIQLDDQSLEEKLVIARRGGYCFEQNGLFERVL 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 490280039  81 REIGFNVRSLLGRVVLANPPQMPPRTHRLLLVEVAGERWIADVGFGGQTLTAPIKLLADIPQQTPHGSYRLVHEGDEWTL 160
Cdd:PRK15047  81 RELGFNVRSLLGRVVLSNPPALPPRTHRLLLVELEGEKWIADVGFGGQTLTAPIRLVADIVQTTPHGEYRLLQEGDDWVL 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 490280039 161 QFNHHEHWQSMYHFDLGRQYASDYVMGNFWSAHWPQSHFRHHLLMCRHLPDGGKMTLTNFHFTHWENNHVVEKIDFADVS 240
Cdd:PRK15047 161 QFNHHQHWQSMYRFDLCEQQQSDYVMGNFWSAHWPQSHFRHHLLMCRHLPDGGKLTLTNFHFTHYENGHAVEQRNLPDVA 240
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|.
gi 490280039 241 ALYEGLQTRFGLGVDDPKHGFSEAALAAVMAAFDTHPEAGK 281
Cdd:PRK15047 241 SLYAVMQEQFGLGVDDAKHGFTVAELAAVMAAFDTHPEAGK 281
NhoA COG2162
Arylamine N-acetyltransferase [Secondary metabolites biosynthesis, transport and catabolism];
3-256 4.72e-112

Arylamine N-acetyltransferase [Secondary metabolites biosynthesis, transport and catabolism];


Pssm-ID: 441765  Cd Length: 256  Bit Score: 323.37  E-value: 4.72e-112
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 490280039   3 PFLRAYFSRLSWTGEPDVSIDTLRELHLQHNSAIPFENLDVLLPREIHLDDGALEEKLIAARRGGYCFEQNGLLERALRE 82
Cdd:COG2162    3 FDLDAYLARIGYSGPPAPTLETLRALHRAHVRAIPFENLDVLLGRPISLDPDALFDKLVRRRRGGYCYELNGLFAALLEA 82
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 490280039  83 IGFNVRSLLGRVVLANP-PQMPPRTHRLLLVEVAGERWIADVGFGGQTLTAPIKLLADIPQQTPHGSYRLVHE-GDEWTL 160
Cdd:COG2162   83 LGFDVTLLAARVRWGGPgGPGPPRTHMALLVTLDGERWLVDVGFGGGTPLEPLPLEDGTEQDQPGGTYRLVRSdDGEWVL 162
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 490280039 161 QFNHHEHWQSMYHFDLGRQYASDYVMGNFWSAHWPQSHFRHHLLMCRHLPDgGKMTLTNFHFTHWENNHVVEKiDFADVS 240
Cdd:COG2162  163 QRRVDGGWRPLYRFDLEPQELADFEVANWYTSTHPDSPFVGNLLVARATPD-GRVTLRGRRLTRRRGGGEEER-TLLSAE 240
                        250
                 ....*....|....*.
gi 490280039 241 ALYEGLQTRFGLGVDD 256
Cdd:COG2162  241 ELAAVLRERFGLDLDD 256
Acetyltransf_2 pfam00797
N-acetyltransferase; Arylamine N-acetyltransferase (NAT) is a cytosolic enzyme of ...
21-257 5.69e-103

N-acetyltransferase; Arylamine N-acetyltransferase (NAT) is a cytosolic enzyme of approximately 30kDa. It facilitates the transfer of an acetyl group from Acetyl Coenzyme A on to a wide range of arylamine, N-hydroxyarylamines and hydrazines. Acetylation of these compounds generally results in inactivation. NAT is found in many species from Mycobacteria (M. tuberculosis, M. smegmatis etc) to man. It was the first enzyme to be observed to have polymorphic activity amongst human individuals. NAT is responsible for the inactivation of Isoniazid (a drug used to treat Tuberculosis) in humans. The NAT protein has also been shown to be involved in the breakdown of folic acid.


Pssm-ID: 395644  Cd Length: 240  Bit Score: 299.96  E-value: 5.69e-103
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 490280039   21 SIDTLRELHLQHNSAIPFENLDVLLPREIHLDDGALEEKLIAARRGGYCFEQNGLLERALREIGFNVRSLLGRVVLANPP 100
Cdd:pfam00797   1 DLETLRELHLHHLRAIPFENLDVHLGEPISLDLEALFDKLVHKRRGGYCYELNGLFYWVLTELGFDVTLLGGRVYWPRPG 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 490280039  101 -QMPPRTHRLLLVEVAGERWIADVGFGGQTLTAPIKLLADIPQQTPHGSYRLVHEGD-EWTLQFNHHEHWQSMYHFDLGR 178
Cdd:pfam00797  81 aYSTPQTHLLLLVTIDGETYLVDVGFGGSTLWAPLELISGKDQPTPHGIFRLVEEGGgTWYLEKDGRDGWVPLYSFTLEP 160
                         170       180       190       200       210       220       230
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 490280039  179 QYASDYVMGNFWSAHWPQSHFRHHLLMCRHLPDgGKMTLTNFHFTHWENNHVVEKIDFADVSALYEGLQTRFGLGVDDP 257
Cdd:pfam00797 161 RQIEDFEVGNDYLQTSPDSHFTTHLLCSRQTPD-GRLTLTGRTLTLRYKDGALVEIRLLTDEEVEDVLKERFGIELDAK 238
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH